Literature DB >> 28058677

Modeling of viral-bacterial coinfections at the molecular level using agonists of innate immunity receptors.

E N Sviriaeva1,2, K V Korneev1,2, M S Drutskaya1,2, S A Nedospasov1,2, D V Kuprash3,4.   

Abstract

The combined effect of innate immunity receptors in viral-bacterial coinfections was studied in vitro using the primary culture of murine macrophages activated by different combinations of ligands of innate immunity receptors belonging to the family of Toll-like receptors. The activation of macrophages first with a viral ligand and then with a bacterial one significantly decreased the expression of proinflammatory cytokine genes. Such attenuation of immune responses may occur during the development of bacterial complications in viral infections.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28058677     DOI: 10.1134/S1607672916060053

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


  12 in total

Review 1.  Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential.

Authors:  M A Stanley
Journal:  Clin Exp Dermatol       Date:  2002-10       Impact factor: 3.470

Review 2.  TLR signaling.

Authors:  T Kawai; S Akira
Journal:  Cell Death Differ       Date:  2006-05       Impact factor: 15.828

3.  Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia.

Authors:  Koenraad F van der Sluijs; Monique Nijhuis; Johannes H M Levels; Sandrine Florquin; Andrew L Mellor; Henk M Jansen; Tom van der Poll; René Lutter
Journal:  J Infect Dis       Date:  2005-12-14       Impact factor: 5.226

4.  The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion.

Authors:  Michael P Schön; Margarete Schön; Karl-Norbert Klotz
Journal:  J Invest Dermatol       Date:  2006-06       Impact factor: 8.551

5.  Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections.

Authors:  Keer Sun; Jianqiang Ye; Daniel R Perez; Dennis W Metzger
Journal:  J Immunol       Date:  2010-12-15       Impact factor: 5.422

6.  Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway.

Authors:  Hiroaki Hemmi; Tsuneyasu Kaisho; Osamu Takeuchi; Shintaro Sato; Hideki Sanjo; Katsuaki Hoshino; Takao Horiuchi; Hideyuki Tomizawa; Kiyoshi Takeda; Shizuo Akira
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

7.  Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection.

Authors:  Amanda M Jamieson; Shuang Yu; Charles H Annicelli; Ruslan Medzhitov
Journal:  Cell Host Microbe       Date:  2010-02-18       Impact factor: 21.023

8.  Imiquimod induces a Toll-like receptor 7-independent increase in intracellular calcium via IP(3) receptor activation.

Authors:  Heehong Hwang; Hyunjung Min; Donghoon Kim; Seong-Woon Yu; Sung Jun Jung; Se-Young Choi; Sung Joong Lee
Journal:  Biochem Biophys Res Commun       Date:  2014-06-24       Impact factor: 3.575

9.  Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages.

Authors:  A N Shakhov; M A Collart; P Vassalli; S A Nedospasov; C V Jongeneel
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

10.  Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection.

Authors:  Arnaud Didierlaurent; John Goulding; Seema Patel; Robert Snelgrove; Lionel Low; Magali Bebien; Toby Lawrence; Leonie S van Rijt; Bart N Lambrecht; Jean-Claude Sirard; Tracy Hussell
Journal:  J Exp Med       Date:  2008-01-28       Impact factor: 14.307

View more
  1 in total

1.  Interdependencies between Toll-like receptors in Leishmania infection.

Authors:  Divanshu Shukla; Ashok Patidar; Uddipan Sarma; Prashant Chauhan; Surya Prakash Pandey; Himanshu Singh Chandel; Neelam Bodhale; Soumya Kanti Ghosh; Carlos Alberto Guzman; Thomas Ebensen; Ricardo Silvestre; Arup Sarkar; Bhaskar Saha; Surajit Bhattacharjee
Journal:  Immunology       Date:  2021-05-26       Impact factor: 7.215

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.